BRIDGEBIO PHARMA- BASED ON POSITIVE RESULTS FROM ATTRIBUTE-CM, SUBMITTED MARKETING AUTHORIZATION APPLICATION TO EMA, WITH DECISION EXPECTED IN 2025

Reuters · 08/30 14:50
BRIDGEBIO PHARMA- BASED ON POSITIVE RESULTS FROM ATTRIBUTE-CM, SUBMITTED MARKETING AUTHORIZATION APPLICATION TO EMA, WITH DECISION EXPECTED IN 2025